PFIZER

Pfizer Limited

Branded prescription and consumer healthcare medicines manufacturer

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

pfizerltd.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹3814.00
Market cap
17,450 Cr
Stock P/E
23.7
P/B
4.15
Dividend yield
4.3%
ROE (FY26)
17.2%
ROCE (FY26)
23.4%
Operating margin (FY26)
33.6%
Debt / equity (FY26)
0.0006
OCF / EBITDA (FY26)
107.0%
OCF / EBITDA (3Y)
82.7%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Pfizer (Pfizer Limited) makes and sells prescription medicines and vaccines in India, and reports a single segment, pharmaceuticals.

Company snapshot

31stBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Net margin of 28.7% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales575 Cr540 Cr547 Cr563 Cr589 Cr538 Cr592 Cr603 Cr642 Cr645 Cr629 Cr653 Cr
Operating expenses (approx.)393 Cr387 Cr357 Cr385 Cr399 Cr392 Cr364 Cr393 Cr412 Cr417 Cr393 Cr406 Cr
EBITDA183 Cr153 Cr189 Cr177 Cr189 Cr146 Cr228 Cr210 Cr230 Cr228 Cr236 Cr248 Cr
OPM %31.7%28.3%34.7%31.5%32.2%27.1%38.4%34.8%35.8%35.4%37.5%37.9%
Other income36 Cr36 Cr75 Cr42 Cr43 Cr43 Cr45 Cr67 Cr42 Cr38 Cr41 Cr45 Cr
Interest3 Cr3 Cr7 Cr2 Cr2 Cr2 Cr3 Cr3 Cr2 Cr2 Cr2 Cr1 Cr
Depreciation15 Cr18 Cr14 Cr15 Cr15 Cr15 Cr16 Cr14 Cr14 Cr14 Cr15 Cr14 Cr
Profit before tax201 Cr176 Cr244 Cr203 Cr215 Cr172 Cr426 Cr260 Cr255 Cr192 Cr269 Cr277 Cr
Tax %25.7%26.1%26.7%25.6%26.4%26.0%22.3%26.1%26.0%26.1%25.7%26.1%
Net profit149 Cr130 Cr179 Cr151 Cr158 Cr128 Cr331 Cr192 Cr189 Cr142 Cr200 Cr204 Cr
EPS (₹)₹32.56₹27.12₹22.33₹32.94₹34.61₹27.89₹72.34₹41.91₹41.32₹31.01₹43.68₹44.69

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,042 Cr1,980 Cr2,082 Cr2,152 Cr2,239 Cr2,611 Cr2,425 Cr2,193 Cr2,281 Cr2,520 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,693 Cr1,480 Cr1,516 Cr1,579 Cr1,526 Cr1,775 Cr1,616 Cr1,558 Cr1,541 Cr1,616 CrSign in free for the trailing twelve months
EBITDA349 Cr500 Cr565 Cr573 Cr712 Cr836 Cr809 Cr635 Cr740 Cr904 CrSign in free for the trailing twelve months
OPM %17.1%25.3%27.2%26.6%31.8%32.0%33.4%29.0%32.4%35.9%Sign in free for the trailing twelve months
Other income101 Cr114 Cr167 Cr184 Cr81 Cr63 Cr101 Cr181 Cr172 Cr188 CrSign in free for the trailing twelve months
Interest0.96 Cr0.42 Cr1 Cr11 Cr15 Cr10 Cr13 Cr15 Cr8 Cr9 CrSign in free for the trailing twelve months
Depreciation63 Cr66 Cr71 Cr103 Cr109 Cr115 Cr106 Cr62 Cr61 Cr58 CrSign in free for the trailing twelve months
Profit before tax517 Cr548 Cr660 Cr642 Cr669 Cr773 Cr824 Cr746 Cr1,016 Cr976 CrSign in free for the trailing twelve months
Tax %34.8%34.3%35.0%20.8%25.6%20.7%24.3%26.1%24.5%26.0%Sign in free for the trailing twelve months
Net profit337 Cr360 Cr429 Cr509 Cr498 Cr613 Cr624 Cr551 Cr768 Cr722 CrSign in free for the trailing twelve months
EPS (₹)₹73.61₹78.70₹93.78₹111.28₹108.77₹133.89₹136.38₹120.51₹167.79₹157.92Sign in free for the trailing twelve months
Dividend payout %————305.3%26.1%47.6%33.3%20.9%104.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital46 Cr46 Cr46 Cr46 Cr46 Cr46 Cr46 Cr46 Cr46 Cr46 Cr
Reserves2,373 Cr2,637 Cr2,966 Cr3,350 Cr2,347 Cr2,819 Cr3,162 Cr3,550 Cr4,172 Cr4,157 Cr
Borrowings3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr
Other liabilities840 Cr1,004 Cr926 Cr1,007 Cr870 Cr1,034 Cr791 Cr631 Cr691 Cr716 Cr
Total liabilities3,261 Cr3,690 Cr3,940 Cr4,405 Cr3,266 Cr3,901 Cr4,001 Cr4,229 Cr4,911 Cr4,922 Cr
Fixed assets (net)83 Cr82 Cr71 Cr215 Cr192 Cr219 Cr178 Cr151 Cr172 Cr136 Cr
CWIP4 Cr1 Cr0 Cr0.76 Cr3 Cr1 Cr8 Cr0.40 Cr8 Cr20 Cr
Investments0 Cr0 Cr32 Cr31 Cr30 Cr28 Cr0 Cr0 Cr0 Cr0 Cr
Loans & advances——5 Cr4 Cr9 Cr0.26 Cr0 Cr0 Cr0 Cr0 Cr
Inventories322 Cr297 Cr387 Cr431 Cr435 Cr449 Cr418 Cr434 Cr476 Cr473 Cr
Trade receivables110 Cr155 Cr172 Cr172 Cr130 Cr124 Cr152 Cr188 Cr193 Cr182 Cr
Cash & bank68 Cr51 Cr74 Cr1,764 Cr157 Cr63 Cr37 Cr112 Cr495 Cr103 Cr
Other assets2,674 Cr3,105 Cr3,199 Cr1,789 Cr2,311 Cr3,016 Cr3,209 Cr3,344 Cr3,568 Cr4,009 Cr
Total assets3,261 Cr3,690 Cr3,940 Cr4,405 Cr3,266 Cr3,901 Cr4,001 Cr4,229 Cr4,911 Cr4,922 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity329 Cr332 Cr98 Cr323 Cr427 Cr667 Cr356 Cr257 Cr660 Cr968 Cr
Cash from investing-250 Cr-238 Cr35 Cr1,530 Cr-469 Cr-575 Cr-36 Cr54 Cr-71 Cr-562 Cr
Cash from financing-83 Cr-110 Cr-110 Cr-164 Cr-1,571 Cr-181 Cr-346 Cr-235 Cr-205 Cr-798 Cr
Net cash flow-3 Cr-17 Cr23 Cr1,690 Cr-1,613 Cr-88 Cr-26 Cr75 Cr383 Cr-392 Cr
Free cash flow (OCF − Capex)304 Cr229 Cr93 Cr306 Cr410 Cr652 Cr291 Cr238 Cr632 Cr942 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %21.4%20.4%21.9%19.2%28.5%27.3%26.1%21.2%24.3%23.4%
ROE %13.9%13.4%14.2%15.0%20.8%21.4%19.5%15.3%18.2%17.2%
Debtor days20283029211723313126
Inventory days302357410455473461440471636556
Days payable364596462451309271229181203254
Cash conversion cycle-42-210-2233186207234322464328
OCF / EBITDA %94.2%66.3%17.3%56.4%60.0%79.8%44.0%40.4%89.1%107.0%
OCF / EBITDA % (3 years)——53.6%46.0%45.9%66.9%61.5%56.1%58.2%82.7%
Debt / equity0.00100.00090.00080.00070.00100.00090.00080.00070.00060.0006
Current ratio2.632.533.033.452.442.773.795.016.176.06
Net debt / EBITDA-0.19—-0.13-3.08-0.22-0.07-0.04-0.17-0.67-0.11